维普期刊资源整合服务平台（V6.5）

137篇 您的检索式：作者名="CALVERLEY A"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Resource assessment methodologies: Current status and future direction显示文摘	Meneley Robert A Calverley Alfred E Logan Kenneth G	2003	AAPG Bulletin2003，87，4：	1
2	Characterisation of COPD heterogeneity in the ECLIPSE cohort 显示文摘	Agusti A Calverley PM Celli B	2010	Respir Res2010，11，1：	1
3	Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease 显示文摘	CALVERLEY P M SANCHEZ TORIL F MCIVOR A	2007	Am J Respir Crit Care Med2007，176，2：	1
4	Salmeterol and fiutica- sone propionate and survival in chronic obstructive pulmonary disease显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，8：	1
5	Re-source assessment methodologies:current status and fu-ture direction显示文摘	Meneley R A Calverley A E Logan K G	2003	AAPG Bulletin2003，87，4：	1
6	The prevention of chronic obstructive pulmonary disease exacerba- tions by salmeterol/flution - casone propionate or tiltopium bromide显示文摘	Wedzicha J A Calverley P M Seemungal T A	2008	Am J Respir Crit Care Med2008，177，：	1
7	Reducing the frequency and severity of excerbationsof chronic obstructive pulmonary disease显示文摘	Calverley P M A	2004	Proc Am Thorac Soc2004，1，：	1
8	Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease显示文摘	Pauwels R A Buist A S Calverley P M A	2012	American journal of respiratory and critical care medicine2012，163，5：	1
9	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	Han MK Agusti A Calverley PM		0，，：	1
10	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease 显示文摘	Calverley P M Anderson J A Celli B	2007	N Engl J Med2007，356，8：	1
11	Chronic obstructive pulmonary disease phenotypes:the future of COPD显示文摘	Han MLK Agusti A Calverley P M	2010	American journal of respiratory and critical care medicine2010，182，5：	1
12	Chronic obstructive pulmo- nary disease phenotypes: The future of COPD 显示文摘	Han MK Agusti A Calverley PM	2010	Am J Respir Crit Care Med2010，182，5：	1
13	Long-acting inhaledanticholinergic therapy improves sleeping oxygen saturation in COPD显示文摘	McNicholas W T Calverley P M Lee A	2004	Eur Respir J2004，23，6：	1
14	Chronic obstruc- tive pulmonary disease phenotypes: the future of COPD显示文摘	Han MLK Agusti A Calverley PM	2010	Am J Respir Crit Care Med2010，182，5：	1
15	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease显示文摘	Peter MA Calverley MD Julie A		0，，08：	1
16	Chronic obstructivepulmonary disease phenotypes:the future of COPD显示文摘	Han M K Agusti A Calverley P M	2010	Am J Re-spir Crit Care Med2010，182，5：	1
17	Chronic obstructive pulmonary disease phenotypes: the future of COPD显示文摘	Han MK Agusti A Calverley PM	2010	Am J Respir Crit Care Med2010，182，5：	1
18	Chronic obstructive pulmonary disease phenotypes:the future of COPD 显示文摘	Han MK Agusti A Calverley PM	2010	Am J Respir Crit Care Med2010，182，5：	1
19	Characterisation of COPD heterogeneity in the ECLIPSE cohort显示文摘	Agusti A Calverley PM Celli B	2010	Respir Res2010，11，：	1
20	Characterisation of COPD heterogeneity in the ECLIPSE cohort显示文摘	Agusti A Calverley PM Celli B		0，，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示